PharmaMar and Eczasibasi sign a licensing agreement for Aplidin ® in Turkey
(Pharmamar) PharmaMar (MSE:PHM) has announced today a licensing agreement with Eczasibasi Group to commercialize the marine-derived anticancer drug Aplidin ® (plitidepsin) in Turkey.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news
More News: Middle East Health